ADVERTISEMENT
You will be redirected to your destination in 10 seconds.
Electronics Industry Search
Advertisement
Email
Print
Reprints/License
RSS
Article tools sponsored by

Clot Buster

A bioactive vinyl fights blood clots in medical devices

Joseph Ogando -- Design News, April 21, 2003

For a glimpse at vinyl's bleeding edge, look no further than the upcoming medical compounds from Teknor Apex (www.teknorapex.com). The company last month announced development plans for polyvinyl chloride (PVC) compounds that prevent blood clot formation in medical devices.

These compounds will be based on an anti-clotting copolymer from VESTOLIT GmBH & Co. KG, a leading European PVC producer (www.vestolit.com, Marl, Germany). According to Peter Galland, Teknor's medical manager, the VESTOLIT copolymer incorporates anti-clotting, Heparin-like molecules into a PVC polymer backbone. Teknor will pair this copolymer with its proven medical PVC compounds.

The resulting bioactive materials will address all sorts of extruded medical tubing—including catheters, and "extracorporeal" circuits that route a patient's blood through medical equipment. Galland adds that the anti-clotting compounds will also be suitable for injection molding—for tubing connectors and related parts. Galland says the physical and mechanical properties of the anti-clotting grades won't deviate from those of standard medical vinyl compounds.

Teknor's new compounds won't be the only anti-clotting—or "anti-thrombogenic"—materials technology on the market. Anti-thrombogenic coatings for PVC, which can be applied to the blood-contact surfaces of medical devices, have been in use for years. But Galland predicts that materials with inherent anti-clotting capabilities will have a leg up in the cost department. "We expect they'll cost at least an order of magnitude less than coated compounds," he says. Some of that cost advantage will spring from how the new materials are fabricated into medical devices. Galland explains that the anti-clotting polymer will be most cost-effective in co-extruded structures—that is, as a thin layer over standard vinyl. "There's no need to have 100% thickness of the bioactive material," he says.

Device manufacturers interested in the new material will soon be able to sample it, Galland says. But it will take time before the new materials can go into production. "It might be another 18 to 36 months," he says.

Advertisement

Sponsored Content

Technology Marketplace

Email
Print
Reprints/License
RSS
Article tools sponsored by
Find a supplier on oemsuppliersearch.com

Talkback


We would love your feedback!


» Submit talk back
Advertisement

DN's Resource Center Get Free Information, Made Easy

Advertisement

Design News Partner Zones

AnarkCAD/CAE Model Clean-Up: Reduce Iterative Cycles
Discuss how Recipe-Based Automation can help create "just-in-time" CAE-ready geometry when CAD models are updated. Register Now


Light Matters: Systems Level Approach to HBLED illumination applications
Its good practice to apply a systems-level approach to high-brightness LED (HBLED) illumination applications. Minimally, the system includes the optical, thermal and electrical characteristics of the of the HBLED, the lens (if any) which is built-in to its package, secondary optics such as external plastic lenses/reflectors to direct the light as your application requires and power driver electronics. Read More


Design Engineers' Portal for Sensing and Machine Safety
Whatever industry you're in, or whatever product you manufacture, the right sensors to automate your plant, and to improve your overall efficiency, quality and safety are a must. You'll find Banner Engineering to be an amazing resource of products, training and people with expertise.

Design News Partner Zone Directory »

Please visit these other Reed Business sites